Cargando…
Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings
BACKGROUND: Following testing in clinical trials, the use of remdesivir for treatment of COVID-19 has been authorized for use in parts of the world, including the USA and Europe. Early authorizations were largely based on results from two clinical trials. A third study published by Wang et al. was u...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301659/ https://www.ncbi.nlm.nih.gov/pubmed/34297766 http://dx.doi.org/10.1371/journal.pone.0255093 |